We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Tomatoes Are Source for Safer Insect Repellent

By Biotechdaily staff writers
Posted on 28 Jun 2002
Researchers have isolated a substance from tomatoes that repels mosquitoes and other insects more effectively than DEET (N, N-diethyl-meta-toluamide), the chemical most commonly used in insect repellents, and with fewer harmful side effects.

Use of the substance called IBI-246 as an insect repellent has been patented by its discoverers at North Carolina State University (Raleigh, USA), and a license for its manufacture has been granted to Insect Biotechnology Inc. (Durham, NC, USA), a company that specializes in developing and marketing biochemical insecticides.

Although DEET is considered safe for normal use by adults, it has been associated with rashes, swelling and itching, eye irritation and, less frequently, slurred speech, confusion and seizures. Products with high concentrations of DEET are considered hazardous to children.


The tomato extract, IBI-246, is already used in the manufacture of cosmetics, so its toxicity has already been studied. "What this means is that the toxicology has been done, which is a big step toward commercialization,” said Dr. Michael Roe. "It is found in tomatoes, it is natural, it can be obtained organically, it is safe, and it is at least as effective as DEET--all features that the public would want for a new-generation insect repellent.”



Related Links:
North Carolina State University
Insect Biotechnology Inc.

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
28 Jun 2002  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
28 Jun 2002  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
28 Jun 2002  |   BioResearch